AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...
The article provides an overview of recent developments in the healthcare sector, including Novo Nordisk's phase-out of ...
Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.
German drugmaker Evotec is attracting takeover interest from U.S.-based Halozyme Therapeutics , Bloomberg News reported on Thursday.
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other ...
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
"Full House" actor Dave Coulier, 65, revealed he has stage 3 non-Hodgkin's lymphoma. ( People) The latest tally of the ...
The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback